Hepatitis D clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

    open to eligible people ages 18-99

    This is a Phase 3, global, randomized, open-label, multicenter trial designed to evaluate the safety and efficacy of chronic treatment with brelovitug (BJT-778) for chronic hepatitis delta virus (HDV) infection. The objective of this study is to test the safety and effectiveness of brelovitug compared to delayed treatment.

    at UC Davis

  • Tobevibart + Elebsiran in Chronic HDV Infection

    Sorry, in progress, not accepting new patients

    This is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic hepatitis delta in comparison to delayed treatment.

    at UCSF

Last updated: